Negative symptoms in individuals at clinical high risk of psychosis

Psychiatry Research

Volumn 196, Issue 2-3, 2012, Pages 220-224

  Piskulic, Danijela ^a   Addington, Jean ^a   Cadenhead, Kristin S ^b   Cannon, Tyrone D ^c   Cornblatt, Barbara A ^d   Heinssen, Robert ^e   Perkins, Diana O ^f   Seidman, Larry J ^g   Tsuang, Ming T ^b,g   Walker, Elaine F ^h   Woods, Scott W ⁱ   McGlashan, Thomas H ⁱ  

^a UNIVERSITY OF CALGARY   (Canada)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d ZUCKER HILLSIDE HOSPITAL   (United States)

^e NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

^f UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^g HARVARD MEDICAL SCHOOL   (United States)

^h EMORY UNIVERSITY   (United States)

ⁱ YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Conversion to psychosis; Longitudinal study; NAPLS1 project; Negative symptoms; Psychosis prodrome

Indexed keywords

NEUROLEPTIC AGENT;

ADULT; ARTICLE; AVOLITION; DETERIORATION IN ROLE FUNCTIONING; DISEASE SEVERITY; DRUG USE; EMOTION; FEMALE; HIGH RISK PATIENT; HUMAN; IDEATIONAL RICHNESS; MAJOR CLINICAL STUDY; MALE; NEGATIVE SYNDROME; PREDICTION; PRIORITY JOURNAL; PSYCHOLOGICAL ASPECT; PSYCHOLOGICAL RATING SCALE; PSYCHOSIS; PSYCHOSOCIAL WITHDRAWAL; SCALE OF PRODROMAL SYMPTOM; SCORING SYSTEM; SOCIAL ISOLATION;

DISEASE PROGRESSION; FACTOR ANALYSIS, STATISTICAL; FEMALE; HUMANS; LONGITUDINAL STUDIES; MALE; PSYCHIATRIC STATUS RATING SCALES; PSYCHOTIC DISORDERS; RISK FACTORS; TIME FACTORS;

EID: 84861458870     PISSN: 01651781     EISSN: 18727123     Source Type: Journal    
DOI: 10.1016/j.psychres.2012.02.018     Document Type: Article

References (26)

1. Addington J., Young J., Addington D. Social outcome in early psychosis. Psychological Medicine 2003, 33(6):1119-1124.
2. Addington J., Cadenhead K.S., Cannon T.D., Cornblatt B., McGlashan T.H., Perkins D.O., Seidman L.J., Tsuang M., Walker E.F., Woods S.W., Heinssen R. North American Prodrome Longitudinal Study: a collaborative multisite approach to prodromal schizophrenia research. Schizophrenia Bulletin 2007, 33:665-672.
3. Addington J., Cornblatt B.A., Cadenhead K.S., Cannon T.D., McGlashan T.H., Perkins D.O., Seidman L.J., Tsuang M.T., Walker E.F., Woods S.W., Heinssen R. At clinical high risk for psychosis: outcome for nonconverters. American Journal of Psychiatry 2011, 168(8):800-805.
4. Blanchard J.J., Cohen A.S. The structure of negative symptoms within schizophrenia: implications for assessment. Schizophrenia Bulletin 2006, 32:238-245.
5. Blanchard J.J., Horan W.P., Collins L.M. Examining the latent structure of negative symptoms: is there a distinct subtype of negative symptom schizophrenia?. Schizophrenia Research 2005, 77:151-165.
6. Cannon T.D., Cadenhead K., Cornblatt B., Woods S.W., Addington J., Walker E., Seidman L.J., Perkins D., Tsuang M., McGlashan T., Heinssen R. Prediction of psychosis in youth at high clinical risk: a multisite longitudinal study in North America. Archives of General Psychiatry 2008, 65:28-37.
7. Cornblatt, B.A., Carrion, R.E., Addington, J., Seidman, L., Walker, E.F., Cannon, T.D., Cadenhead, K.S., McGlashan, T.H., Perkins, D.O., Tsuang, M.T., Woods, S.W., Heinssen, R., Lencz, T., 2011. Risk factors for psychosis: Impaired social and role functioning. Schizophrenia Bulletin; e-publication 10 November; doi: . doi:10.1093/schbul/sbr136.
8. Faerden A., Friis S., Agartz I., Barret E.A., Nesvag R., Finset A., Melle I. Apathy and functioning in first-episode psychosis. Psychiatric Services 2009, 60:1495-1503.
9. First M., Spitzer R., Gibbon M., Williams B., Williams J. Structured Clinical Interview for DSM-IV Axis I Disorders 1995, New York State Psychiatric Institute, New York. Patient Edition.
10. Foussias G., Remington G. Negative symptoms in schizophrenia: avolition and Occam's razor. Schizophrenia Bulletin 2010, 36:359-369.
11. Hawkins K.A., McGlashan T.H., Quinlan D., Miller T.J., Perkins D.O., Zipursky R.B., Addington J., Woods S.W. Factorial structure of the Scale of Prodromal Symptoms. Schizophrenia Research 2004, 68:339-347.
12. Johnstone E.C., Ebmeier K.P., Miller P., Owens D.G., Lawrie S.M. Predicting schizophrenia: findings from the Edinburgh High-Risk Study. British Journal of Psychiatry 2005, 186:18-25.
13. Kirkpatrick B., Fenton W.S., Carpenter W.T., Marder S.R. The NIMH-MATRICS consensus statement on negative symptoms. Schizophrenia Bulletin 2006, 32:214-219.
14. Kwapil T.R. Social anhedonia as a predictor of the development of schizophrenia spectrum disorders. Journal of Abnormal Psychology 1998, 107:558-565.
15. Lencz T., Smith C.W., Auther A., Correll C.U., Cornblatt B. Nonspecific and attenuated negative symptoms in patients at clinical high-risk for schizophrenia. Schizophrenia Research 2004, 68:37-48.
16. Mason O., Startup M., Halpin S., Schall U., Conrad A., Carr V. Risk factors for transition to first episode psychosis among individuals with 'at-risk mental states'. Schizophrenia Research 2004, 71:227-237.
17. McGlashan T., Walsh B., Woods S. The Psychosis-Risk Syndrome: Handbook for Diagnosis and Follow-up 2010, Oxford University Press, New York.
18. Mueser K.T., Sayers S.L., Schooler N.R., Mance R.M., Haas G.L. A multisite investigation of the reliability of the Scale for the Assessment of Negative Symptoms. American Journal of Psychiatry 1994, 151:1453-1462.
19. Sayers S.L., Curran P.J., Mueser K.T. Factor structure and construct validity of the Scales for the Assessment of Negative Symptoms. Psychological Assessment 1996, 8:269-280.
20. Tabachnik B.G., Fidel L.S. Using Multivariate Statistics 2001, Needham Heights, MA. 4th ed.
21. Velthorst E., Nieman D.H., Becker H.E., van de Fliert R., Dingemans P.M., Klassenn R., de Haan L., van Amelsvoort T., Linszen D.H. Baseline differences in clinical symptomatology between ultra high risk subjects with and without a transition to psychosis. Schizophrenia Research 2009, 109:60-65.
22. Yung A.R., McGorry P.D. The initial prodrome in psychosis: descriptive and qualitative aspects. Australia and New Zealand Journal of Psychiatry 1996, 30:587-599.
23. Yung A.R., McGorry P.D. The prodromal phase of first-episode psychosis: past and current conceptualizations. Schizophrenia Bulletin 1996, 22:353-370.
24. Yung A.R., Phillips L.J., Yuen H.P., Francey S.M., McFarlane C.A., Hallgren M., McGorry P.D. Psychosis prediction: 12-month follow up of a high-risk ("prodromal") group. Schizophrenia Research 2003, 60:21-32.
25. Yung A.R., Phillips L.J., Yuen H.P., McGorry P.D. Risk factors for psychosis in an ultra high-risk group: psychopathology and clinical features. Schizophrenia Research 2004, 67:131-142.
26. Yung A.R., Yuen H.P., McGorry P.D., Phillips L.J., Kelly D., Dell'Olio M., Francey S.M., Cosgrave E.M., Killackey E., Stanford C., Godfrey K., Buckby J. Mapping the onset of psychosis: the Comprehensive Assessment of At-Risk Mental States. Australia and New Zealand Journal of Psychiatry 2005, 39:964-971.